Qube Research & Technologies (QRT)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Qube Research & Technologies (QRT)'s NVS Position: Q1 2026 in Review
Qube Research & Technologies (QRT) increased its Novartis (NVS) stake by 46% in Q1 2026, buying an estimated $8.36M and bringing the position to 173,137 shares worth $26.4M. The position accounts for 0.03% of the portfolio, ranked #720.
Qube Research & Technologies (QRT) first reported a position in NVS in Q4 2019 and has held it in 21 quarters since. The position peaked at $70.6M in Q1 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Qube Research & Technologies (QRT) held 173,137 shares of Novartis worth $26.4M as of Q1 2026.
- Qube Research & Technologies (QRT) bought 54,510 Novartis shares in Q1 2026, an estimated $8.36M.
- Novartis made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #720 holding.
- Qube Research & Technologies (QRT) first reported a position in Novartis in Q4 2019 and has held it in 21 quarters since.
- Qube Research & Technologies (QRT)'s Novartis position peaked at $70.6M in Q1 2024.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.